Skip to main content
. 2020 Aug 1;9(8):2471. doi: 10.3390/jcm9082471

Table A1.

Detailed characteristics of the patients.

Sex Age Max Tumor Size (cm) Tumor Grade Surgical Margin Radiological Response to Treatment (by RECIST) Response to Treatment According to EORTC-STBSG Response Score Metastases Alive
1. M 62 12 High R0 SD D Yes No
2. M 38 20 Low R0 NA D No Yes
3. F 67 15 High R0 PR C No Yes
4. F 28 14 High R0 PR C No Yes
5. F 60 13 Low R1 NA E No Yes
6. F 48 11 Low R0 PR D No Yes
7. M 67 13 High R0 NA C Yes Yes
8. F 24 18 Low R0 NA C No Yes
9. F 28 15 Low R0 NA E No Yes
10. F 32 15 Low R0 SD E No Yes
11. F 43 5 Low R0 PR A No Yes
12. M 44 16 Low R0 NA D No Yes
13. M 32 13 Low R1 NA D No Yes
14. F 82 12 High R0 NA D No Yes
15. M 31 20 High R0 PR C Yes No
16. M 28 9 Low R0 PR E No Yes
17. F 40 14 High R0 NA E No Yes
18. M 50 5 Low R0 NA D No Yes
19. F 33 10 Low R0 NA C No Yes
20. F 64 9 Low R0 NA D No Yes
21. M 58 14 High R0 NA D No Yes
22. F 43 7 Low R0 NA C No Yes
23. M 55 5 Low R0 SD E No Yes
24. M 30 10 Low R0 NA E No Yes
25. M 36 15 Low R0 SD E No Yes
26. M 59 15 High R0 SD C Yes Yes
27. M 35 20 Low R0 PR D No Yes

M-male; F-female; NA- not assessed, PR- partial response, SD- stable disease.